针对针对性抗癌剂的新严重安全警告,其最初的FDA批准后
Dimitar Stefanovski1,2, Damjan Manevski3, Domen Ribnikar1,2
1Division of Medical Oncology, Institute of Oncology Ljubljana, Zaloška Cesta 2, 1000 Ljubljana, Slovenia.
Cancers
|February 26, 2025
概括
针对性抗癌药物 (TAA) 的新严重不良药物反应 (ADR) 在批准后的多年内继续出现在更新的药物标签上. 这凸显了这些重要的癌症治疗方法不断变化的安全性.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 针对性抗癌药物 (TAA) 与批准后出现的安全问题有关.
- 了解严重药物不良反应 (ADR) 的长期出现对于患者安全至关重要.
研究的目的:
- 调查更新的TAA药物标签中持续出现严重和可能致命的副作用.
- 为了确定随着时间的推移是否可以预测新的ADRs的出现.
主要方法:
- 对2013年7月之前批准的TAA更新的美国FDA药品标签的分析.
- 在警告和预防措施和盒装警告部分中识别严重和可能致命的副作用.
- 统计建模以评估时间,药物类型 (小分子与单克隆抗体) 以及伴随诊断对ADR出现的影响.
主要成果:
- 时间是新的警告和预防措施 (WP) 和盒式警告 (BW) 的重要预测因素.
- 与单克隆抗体相比,小分子TAA显示出明显更多的新WP.
- 伴随性诊断没有影响新的副作用的出现.
结论:
- 对TAA的严重不良反应在最初批准数年后的更新标签上继续出现.
- 经批准的TAA的风险-收益概况是动态的,需要持续监测.
- 瘤学家,监管机构和支付人必须始终意识到这些不断变化的安全数据.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
172
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
172
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K


